Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy
- 14 November 2021
- journal article
- research article
- Published by Springer Nature in Breast Cancer
- Vol. 29 (2) , 302-313
Abstract
We re-evaluated acute and early-late toxicity-related factors among pre-pectoral immediate tissue expander/implant (TE/I) breast reconstruction (BR) unselected, first-era, cases, including previous breast radiation treatment and post-mastectomy radiation therapy (PMRT). A retrospective analysis of 146 (117 therapeutic and 29 prophylactic) pre-pectoral reconstructions, between 2012 and 2016, considered patient-related (age, body mass index [BMI], smoke-history, comorbidity, BRCA mutation), and treatment-related characteristics (previous irradiation, axillary surgery, PMRT, pre- and postoperative chemotherapy, endocrine therapy, and target-therapy). Safety was evaluated as acute and early-late complications, and TE/I failures. At multivariate analysis of the 146 cases (117 patients submitted to BR) a significant factor related to acute toxicity was: BMI ≥ 25 (31.3% [≥ 25] vs 8.8% [< 25]; OR 4.44, 95% CI 1.56–12.6; p = 0.003), while previous breast surgery on ipsilateral side presented a borderline significance (31.6% [previous surgery] vs 7.4% [no previous surgery]; OR 3.74, 95% CI 0.97–14.40; p = 0.055). Factors significantly related to TE/I failure were: current or previous smoking exposition (13.8% [smokers] vs 2.6% [non-smokers]; OR 7.32, 95% CI 1.37–39.08; p = 0.02) and preoperative chemotherapy (18.8% [yes] vs 3.5% [no]; OR 8.16, 95% CI 1.29–51.63; p = 0.026). At 4-year median follow-up, 3 deaths, 5 locoregional recurrences, and 14 distant metastases occurred. Immediate pre-pectoral BR is safe and effective, with low rates of acute and early-late complications. BMI and previous breast surgery were related to higher complications but not failure; smoking and preoperative chemotherapy were related to TE/I explant. Previous RT and PMRT were related neither to early-late toxicity nor failure.Keywords
This publication has 47 references indexed in Scilit:
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort studyBreast Cancer Research and Treatment, 2011
- Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstructionRadiotherapy and Oncology, 2010
- Immediate postmastectomy reconstruction is associated with improved breast cancer‐specific survivalCancer, 2009
- Predicting Complications following Expander/Implant Breast Reconstruction: An Outcomes Analysis Based on Preoperative Clinical RiskPlastic and Reconstructive Surgery, 2008
- Breast Cancer Recurrence following Prosthetic, Postmastectomy Reconstruction: Incidence, Detection, and TreatmentPlastic and Reconstructive Surgery, 2008
- Selective Use of Serial Expansion in Breast ReconstructionAnnals of Plastic Surgery, 1983
- Breast Reconstruction after Mastectomy Using the Temporary ExpanderPlastic and Reconstructive Surgery, 1982
- Symposium on Aesthetic Surgery of the BreastPlastic and Reconstructive Surgery, 1979
- RECONSTRUCTION OF THE FEMALE BREAST FOLLOWING RADICAL MASTECTOMYPlastic and Reconstructive Surgery, 1971